05/09/2024 6:10 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 6:41 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 7:29 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024 7:15 AM | ASLAN Pharmaceuticals (Filer)
| Form 424B5 | |
04/12/2024 7:10 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024 5:37 AM | ASLAN Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/12/2024 5:27 AM | ASLAN Pharmaceuticals (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
|
04/12/2024 5:05 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2024 11:15 PM | ASLAN Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2024 1:11 PM | ASLAN Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/21/2024 3:42 PM | ASLAN Pharmaceuticals (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G | |
03/14/2024 5:24 AM | ASLAN Pharmaceuticals (Filer)
| Form 424B5 | |
03/13/2024 6:27 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 7:03 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 3:45 PM | ASLAN Pharmaceuticals (Subject) K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 9:22 AM | ASLAN Pharmaceuticals (Subject) BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/06/2024 9:38 AM | ASLAN Pharmaceuticals (Subject) UBS Group AG (Filed by)
| Form SC 13G | |
01/24/2024 6:52 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024 6:02 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/22/2023 3:24 PM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023 3:42 PM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/27/2023 7:14 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2023 7:32 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2023 5:08 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2023 6:33 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K/A | |
08/11/2023 6:10 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/20/2023 6:55 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 6:59 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 7:09 AM | ASLAN Pharmaceuticals (Filer)
| Form 424B5 | |
07/06/2023 7:11 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023 3:15 PM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/22/2023 7:32 AM | ASLAN Pharmaceuticals (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |